Skip header and navigation

8 records – page 1 of 1.

Date Research Question / Title Unique ID Research Team
March 10, 2022 What is the safety/efficacy of the Novavax COVID-19 vaccine? EOC220302 RR Table EOC
March 10, 2022 What is the safety/efficacy of the Novavax COVID-19 vaccine? EOC220302 RR EOC
August 24, 2021 What are other jurisdictions offering for incentive-based COVID-19 vaccine campaigns? EOC210501v2 RR Table EOC
August 24, 2021 What are other jurisdictions offering for incentive-based COVID-19 vaccine campaigns? EOC210501v2 RR EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR Table EOC
March 18, 2021 What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)? EOC031001 RR EOC
January 19, 2021 How are other jurisdictions distributing COVID-19 vaccines in non-healthcare worker environments and what is the rationale for those distribution models? PH011401 RR Public Health

8 records – page 1 of 1.